Palatin Technologies (PTN) Inventory Average (2020 - 2023)
Palatin Technologies' (PTN) quarterly Inventory Average came in at $1.1 million in Q3 2023, up 17.85% on a YoY basis from $901223.0 in Q3 2022, and up 83.75% quarter-over-quarter from $578016.5 in Q2 2023.
Analysis
Palatin Technologies (PTN) Inventory Average (2020 - 2023) Analysis & Trends
Palatin Technologies (PTN) has reported Inventory Average for 4 consecutive years, with $1.1 million the latest figure, recorded in Q3 2023.
- For the quarter ending Q3 2023, Inventory Average rose 17.85% year-over-year to $1.1 million; the trailing twelve-month figure through Sep 2023 stood at $1.1 million (up 17.85% YoY), and the FY2023 full-year result was $735235.5, down 30.19% from the prior year.
- Inventory Average rose to $1.1 million in Q3 2023 per PTN's latest filing, from $578016.5 in the prior quarter.
- Across five years, Inventory Average topped out at $6.1 million in Q1 2021 and bottomed at $578016.5 in Q2 2023.
- Historically, Inventory Average has averaged $2.0 million across 4 years, with a median of $1.1 million in 2022.
- The sharpest annual moves came in 2022 and 2023: Inventory Average plunged 82.62% in 2022, then increased 17.85% in 2023.
- Over 4 years, Inventory Average stood at $5.9 million in 2020, then tumbled by 81.5% to $1.1 million in 2021, then retreated by 26.05% to $808621.5 in 2022, then jumped by 31.35% to $1.1 million in 2023.
- According to Business Quant data, Inventory Average over the past three periods registered $1.1 million, $578016.5, and $694650.5 for Q3 2023, Q2 2023, and Q1 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 6.20 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 1.93 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 1.77 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 3.09 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 213.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 90.57 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 2.17 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Palatin Technologies | 46.98 Mn | 46.98 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 1.06 Mn |
| Jun 30, 2023 | 578,016.50 |
| Mar 31, 2023 | 694,650.50 |
| Dec 31, 2022 | 808,621.50 |
| Sep 30, 2022 | 901,223.00 |
| Jun 30, 2022 | 988,229.50 |
| Mar 31, 2022 | 1.06 Mn |
| Dec 31, 2021 | 1.09 Mn |
| Sep 30, 2021 | 1.14 Mn |
| Jun 30, 2021 | 3.64 Mn |
| Mar 31, 2021 | 6.07 Mn |
| Dec 31, 2020 | 5.91 Mn |